HCV+ kidneys for HCV+ patients: transplant study yields impressive results

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Receipt of HCV+ donor kidneys followed by direct-acting antiviral (DAA) therapy is a viable option for HCV+ patients with end-stage renal disease.

Why this matters

  • The approach expanded the donor organ pool, reducing mean waitlist time by ~3.5 y.
  • Having normal kidney function...